Factors that are associated with increased non-adherence rates in patients with IBD treated with anti-TNF agents include female gender, smoking, treatment beliefs and illness perceptions, along with psychological comorbidities, especially depression and anxiety [126,127,129]. Here, TNF is linked to depressive symptom measurement.